申请人:Syntex (U.S.A.) Inc.
公开号:US04766127A1
公开(公告)日:1988-08-23
The invention concerns a method of inhibiting thromboxane synthetase with a compound of the formula: ##STR1## or a pharmaceutically acceptable salt or ester thereof, in a mammal having a disease characterized by elevated thromboxane levels or an imbalance of prostacyclinthromboxane levels.
这项发明涉及一种利用以下化合物抑制血栓素合酶的方法:##STR1##或其药用可接受的盐或酯,在患有血栓素水平升高或前列环素/血栓素水平失衡的哺乳动物中。